These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34957911)

  • 1. Screening of phytochemicals as potential anti-breast cancer agents targeting HER2: an in-silico approach.
    Lamichhane S; Rai RP; Khatri A; Adhikari R; Shrestha BG; Shrestha SK
    J Biomol Struct Dyn; 2023 Feb; 41(3):897-911. PubMed ID: 34957911
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Das SK; Deka SJ; Paul D; Gupta DD; Das TJ; Maravi DK; Tag H; Hui PK
    J Biomol Struct Dyn; 2022 Sep; 40(15):6857-6867. PubMed ID: 33625319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular docking and dynamic simulation to identify potential phytocompound inhibitors for EGFR and HER2 as anti-breast cancer agents.
    Prabhavathi H; Dasegowda KR; Renukananda KH; Karunakar P; Lingaraju K; Raja Naika H
    J Biomol Struct Dyn; 2022 Jul; 40(10):4713-4724. PubMed ID: 33345701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of potential HER2 inhibitors from
    Balogun TA; Iqbal MN; Saibu OA; Akintubosun MO; Lateef OM; Nneka UC; Abdullateef OT; Omoboyowa DA
    J Biomol Struct Dyn; 2022; 40(23):12772-12784. PubMed ID: 34514973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular docking and molecular dynamic studies: screening of phytochemicals against EGFR, HER2, estrogen and NF-KB receptors for their potential use in breast cancer.
    Purawarga Matada GS; Dhiwar PS; Abbas N; Singh E; Ghara A; Das A; Bhargava SV
    J Biomol Struct Dyn; 2022 Aug; 40(13):6183-6192. PubMed ID: 33525984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of phytochemicals from
    Yasmeen N; Ahmad Chaudhary A; K Niraj RR; Lakhawat SS; Sharma PK; Kumar V
    J Biomol Struct Dyn; 2023 Dec; ():1-43. PubMed ID: 38141177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential inhibitors of HER2 targeting breast cancer-a structure-based drug design approach.
    Singh G; Al-Fahad D; Al-Zrkani MK; Chaudhuri TK; Soni H; Tandon S; Narasimhaji CV; Azam F; Patil R
    J Biomol Struct Dyn; 2024 Sep; 42(15):8184-8201. PubMed ID: 37565730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-silico Design, ADMET Screening, MM-GBSA Binding Free Energy of Some Novel Isoxazole Substituted 9-Anilinoacridines as HER2 Inhibitors Targeting Breast Cancer.
    Kalirajan R; Pandiselvi A; Gowramma B; Balachandran P
    Curr Drug Res Rev; 2019; 11(2):118-128. PubMed ID: 31513003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of HER2 inhibitors from curcumin derivatives using combination of
    Saibu OA; Singh G; Olugbodi SA; Oluwafemi AT; Ajayi TM; Hammed SO; Oladipo OO; Odunitan TT; Omoboyowa DA
    J Biomol Struct Dyn; 2023; 41(21):12328-12337. PubMed ID: 36752338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting natural compounds against HER2 kinase domain as potential anticancer drugs applying pharmacophore based molecular modelling approaches.
    Rampogu S; Son M; Baek A; Park C; Rana RM; Zeb A; Parameswaran S; Lee KW
    Comput Biol Chem; 2018 Jun; 74():327-338. PubMed ID: 29702367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of tyrosine kinase inhibitors from Panax bipinnatifidus and Panax pseudoginseng for RTK-HER2 and VEGFR2 receptors, by in silico approach.
    Paul D; Mahanta S; Tag H; Das SK; Das Gupta D; Tanti B; Ananthan R; Das R; Jambhulkar S; Hui PK
    Mol Divers; 2022 Aug; 26(4):1933-1955. PubMed ID: 34554395
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Sharma P; Joshi T; Mathpal S; Chandra S; Tamta S
    J Biomol Struct Dyn; 2022; 40(21):10543-10560. PubMed ID: 34225570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of pseudobaptigenin as a novel polyphenol-based multi-target antagonist of different hormone receptors for breast cancer therapeutics.
    Ray S; Gupta S; Panda G; Chatterjee P; Das A; Patawri P; Hosseinzadeh P; Ray A; Banerjee S
    J Biomol Struct Dyn; 2024 Jul; 42(11):5502-5514. PubMed ID: 37409735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational investigation of
    Yousaf MA; Anwer SA; Basheera S; Sivanandan S
    J Biomol Struct Dyn; 2024; 42(4):1901-1923. PubMed ID: 37154824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Docking and Simulation-Binding Analysis of Plant Phytochemicals with the Hepatocellular Carcinoma Targets Epidermal Growth Factor Receptor and Caspase-9.
    Mustafa G; Younas S; Mahrosh HS; Albeshr MF; Bhat EA
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative anti-proliferative effects of potential HER2 inhibitors on a panel of breast cancer cell lines.
    Zalloum H; AbuThiab T; Hameduh T; AlBayyari S; Zalloum W; Abu-Irmaileh B; Mubarak MS; Zihlif M
    Breast Cancer; 2020 Mar; 27(2):213-224. PubMed ID: 31559601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multitier virtual screening study of phytoconstituents as Myeloid Cell Leukemias 1 inhibitors.
    Liu W; Khalid M; Wahab S; Faizan Siddiqui M; Hasan Khan S; Sadiq M; Khatoon Z
    J Biomol Struct Dyn; 2024 Jul; 42(10):5219-5228. PubMed ID: 37418235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based pharmacophore modeling, virtual screening and simulation studies for the identification of potent anticancerous phytochemical lead targeting cyclin-dependent kinase 2.
    Sharma M; Sharma N; Muddassir M; Rahman QI; Dwivedi UN; Akhtar S
    J Biomol Struct Dyn; 2022; 40(20):9815-9832. PubMed ID: 34151738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational binding affinity and molecular dynamic characterization of annonaceous acetogenins at nucleotide binding domain (NBD) of multi-drug resistance ATP-binding cassette sub-family B member 1 (ABCB1).
    Manoharan JP; Nirmala Karunakaran K; Vidyalakshmi S; Dhananjayan K
    J Biomol Struct Dyn; 2023 Feb; 41(3):821-832. PubMed ID: 34907862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Screening of Some Phytochemicals to Identify Best Modulators for Ligand Binding Domain of Estrogen Receptor Alpha.
    Alagarsamy V; Sundar PS; Solomon VR; Murugesan S; Muzaffar-Ur-Rehman M; Kulkarni VS; Sulthana MT; Narendhar B; Sabarees G
    Curr Pharm Des; 2024; 30(20):1599-1609. PubMed ID: 38698754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.